IL-2 in Refractory Autoimmune Encephalitis

NCT02714959 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Encephalitis

Interventions

DRUG: Proleukin

Sponsor

Seoul National University Hospital